The big 6
The causes and repercussions for increasing drug resistance are multifaceted in a globalized world and need to be addressed at many levels, but crucially they need to be tackled there where it matters most – at the bedside of infected patients. Looking at the imminent health-threats – i.e. the spread of hyperepidemic and – hypervirulent and extensive drug resistant bacterial species – the focus lies on the following species:
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Carbapenem-resistant Enterobacteriaceae (CRE)
- Other multi-drug resistant gut bacteria (e.g., VRE, Serratia marcescens, Clostridium difficile)
- Carbapenem-resistant Acinetobacter baumannii (CRAb)
- Extensive drug resistant Pseudomonas aeruginosa (XDR-PA)
- Extensively and multi-drug resistant Mycobacterium tuberculosis (MDR/XDR-TB)
- Streptococcus pneumoniae
![the-big-6](http://cesam-nnl.com/wp-content/uploads/2016/09/the-big-6.jpg)